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DURING the last 30 years it has become apparent that multiple myeloma, which
earlier was considered a very rare disease (Geschicter and Copeland, 1928; and
Atkinson, 1937), is not as uncommon as was previously believed (Bayrd and Heck,
1947; Snapper et al., 1953; Waldenstrom, 1960; Martin, 1961). While in their
review in 1928 Geschicter and Copeland could find only 425 cases reported in
the world literature, recently series in excess of 100 cases have been reported from
large centres (McMahon and Clark, 1956; Innes and Newall, 1961; Martin, 1961;
Study Committee, 1964; Griffiths, 1966; Nordenson, 1966; Carbone et al., 1967).
Most reports dealing with this disease have come from Western Europe and
North America, and the disease is considered to be uncommon in Asia and Africa
(Doll et al., 1966). Reports from the United States indicate that the disease has
similar incidence in the American negro to that in the white American (Gilliam,
1953; Carson et al., 1955; Study Committee, 1964; Carbone et al., 1967). In
view of the fact that the disease is uncommon in the African negro, it was con-
sidered that a study of the incidence and the clinico-pathological aspects of this
disease in Jamaica, a West Indian island populated mainly by negroes of West
African origin, could be of interest.
The term " multiple myeloma " is used to include the whole spectrum of
malignant plasma cell disorders, namely multiple myeloma, solitary intra-osseous
plasmocytoma, and solitary extra-osseous plasmocytoma. Plasma cell leukaemia
is not considered as a separate entity but as a late, or terminal event in the course
of multiple myeloma (Rappaport, 1966).
MATERIAL AND METHODS
This study, which covers a 10-year period (1957-66), is mainly retrospective.
It is based on the records of the Jamaica Cancer Registry and the departmenits of
Pathology, Haematology, Chemical Pathology, and Radiology of the University
Hospital and the Kingston Public Hospital, which are the only two hospitals in
Jamaica which have more sophisticated investigation facilities. All the relevant
bone marrow smears, biopsy and post mortem slides were examined together with
all biochemical, haematological, and radiological data available. Patients' case
notes were examined and the relevant data extracted. A few cases were rejected
due to insufficient evidence. Therefore this material includes all the proven cases
of multiple myeloma and solitary plasmocytoma diagnosed in Jamaica during the
period under study. The average population of Jamaica during this period was
approximately 1P5 million.
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RESULTS
During the period under study 101 cases of multiple myeloma, 2 cases of
solitary intra-osseous plasmocytoma and 1 case of solitary extra-osseous plasmo-
cytoma were encountered.
Age and sex incidence.-Fig. 1 shows the age and sex incidence in the preseilt
study. The age of the patients at the time of diagnosis ranged from 35 to 74
years in males, and from 37 to 76 years in females. There were 55 males and 49
females. The sex incidence ratio was male to female 11 : 1.
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-The age and sex incidence of patients.
Racial incidence. All but 2 patients were either pure negroes or of predom-
inantly negro origin. The remaining 2 were a white female and a Chinese male.
This is consistent with the racial distribution of the Jamaican population.
Duration of symptoms. The duration of symptoms was 6 months or less in
80% of cases. In 3 cases the disease was discovered as an incidental finding.
Presenting symptoms.-The most frequent presenting symptom was pain,
which was present in 87% of cases. The most frequent site was the back, par-
ticularly the lumbar and lower thoracic regions. Weakness, malaise, loss of
weight, as well as bleeding manifestations and neurological symptoms were other
symptoms.
Physical signs on admnission. Pallor indicating anaemia (65%), loss of weight
(40%0), bone tenderness and pathological fractures (25%) were the most common
findings on admission. Evidence of infection (20%), neurological complications
(15%), and bleeding manifestations (12.5%) were also common. Hepatomegaly
was observed in 360/, and splenomegaly in 12% of cases on admission.
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Investigations on Admission
Haematological
Anaemia was present on admission in 74% of cases and was severe (below
9 g./100 ml.) in 50%. The anaemia was normochromic and normocytic and
occasionally microcytic and hypochromic. Leucoerythroblastic anaemia was
present in 21% of cases. Macrocytic anaemia was uncommon.
The white cell count did not show any characteristic changes. Plasma cells
were observed in the peripheral blood on admission in 14% of cases. Plasma
cell leukaemia was encountered in 3 cases, which were all in the advanced stages
of the disease. Erythrocyte sedimentation rate in excess of 35 mm. in one hour
(Westergren) was observed in 94% ofcases, and in 59% it was in excess of 100 mm.
Bone marrow examination showed infiltration by abnormal plasma cells in
varying numbers, from 10% to nearly complete replacement.
Biochemical
Hyperproteinaemia in excess of 8 g./100 ml. was observed in 60% of cases,
and hyperglobulinaemia in excess of 4 g./100 ml. in 76%. Serum albumin was
reduced below 3-5 g./100 ml. in 70% of cases. An abnormal band on electro-
phoresis was observed in 90.9% of cases. The abnormal band showed a mobility
in the gamma region in 47%0 of cases, in the beta region in 21.3%, between beta
and gamma (" M " band) in 18.1%, and in the alpha-2 region in 4.5% of cases.
There was a relationship between the presence of an abnormal globulin with a
mobility in the beta region, and a more atypical cytology. There was no correla-
tion between the prognosis and cytology, or electrophoretic mobility.
Bence-Jones protein was detected in50%0 ofcases. It was detected by electro-
phoresis of concentrated urine in some cases where the classical heat test was
negative. There was no correlation between the type of abnormal globulin and
the presence of Bence-Jones proteinuria. Cryoglobulinaemia was observed in
only 2 cases, but in view of the high normal temperature, it may not have mani-
fested itself in a number of cases. Hypercalcaemia was observed in 39%0 of
cases. There was good correlation between hypercalcaemia and poor prognosis.
The serum inorganic phosphorus was usually normal, except in patients in renal
failure. The serum alkaline phosphatase was found to be normal in 87/5% of
cases, and two thirds of the cases with raised alkaline phosphatase were found to
have large pathological fractures. In some ofthese cases the alkaline phosphatase
returned to normal when the fractures had healed. Serum uric acid was estimated
in only a few cases, but it was found to be raised in most of them. Raised blood
urea was related to Bence-Jones proteinuria, and was associated with poor
prognosis.
Radiological
The majority of patients exhibited radiological abnormalities. These mani-
fested themselves most commonly as generalised osteoporosis, but classical osteo-
lytic lesions were also very common. In 10.6% of cases no radiological abnor-
mality was demonstrable, and in one case osteosclerosis, which is very uncommon
in multiple myeloma, was present. Pathological fractures were common, and
sometimes the disease first manifested itself in this manner. The fractures were
most common in the spine and in the ribs, but were also observed in the long
bones. The bone lesions were often very extensive.
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'T'hie lenigtlh of survival, either fromn the oniset of svmptomns or froom the timne of
diagncosis, was very short. Fig. 2 slhowTs the length of survival after diagnosis.
TherewA-as nio differ-enice in survivalbetw-een the sexes, and therewA-asnIo significant
differenice in survival between the younger anid the older age groups. The axverage
survival from the oinset of symptoms was 8X4 months in males, aind 6-4 months in
females. The average survival from the time of diagniosis wA-as 2-4 monitlhs in
mnales. aiid 2-1 months in females.
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FIG. 2.--The lenigth of survival after dliagnosis.
Post M11ortem Findinys
Post mortemi examninations wAere performed in 32 cases. The milost comlilmioll
catuse of death -Nas bronchopneumonia, and infectious complications w-ere enI-
countered in the majority of cases. I3leeding manifestations wN-ere not an unlcom-
mnoni cauise ofdeath, and in 3 cases death was due to massive pulmonary embolism.
a cause of death not recorded in otlher reported series. Renal failure w-V-as n1ot
uncotm moni. oftein occurrinig in conjunctiion wxith other complicatiolls.
Involvemeent of the skeletal system wNas observed in all the cases examinied.
Tlhe extent of the involvemiienit varied. ancd in some cases the typical lesions hiad
to be searched for. Osteoporosis Na-s very comimnoni. Splenic enlargement was
observed in 35.70, of cases. Microscopic involvement of the spleen was observed
ill 75°O ofcases, but tumouir deposits Awere niot observed macroscopicallv. Hepatic
enilargetmienit, wAas observed in 64-30o of cases. and in 530o there NAas microscopical
involvemen1t. In 2 cases tumour niodules simulating carcinomiatous metastases
were observed mnacroscopically. Histologically the inifiltrates were usuallly portal
in distribution. Enlargemenit of the intra-abdomiinal and/or the mediastinal
lymlph niodes wAas observed in 46 6°O of cases. Histologically lymphl node infil-
trationi by atypical plasma cells wNas observed in 570o of cases. Renal involve-
ment was comI1mon1. A classical picture of
" myeloma kidnev " wA-as observed in
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66% of cases. In 2 cases there were nodular tumour deposits observed macro-
scopically, and 3900 of cases exhibited microscopical involvement. In 32% of
cases there was evidence of either chronic or acute pyelonephritis, and in some
of these cases there were multiple small cortical abscesses. Amyloid deposition
was present in 21% of the kidneys examined. Extra-medullary lesions were
observed in manv other sites, and their distribution is shown in Fig. 3.
SPLEEN
LYMPH NODES
LIVER
KIDNEY
AMYLOIDOSIS
GASTRO-INTESTINAL TRACT
EXTRADURAL SPACE
ADRENAL
THYROID
TESTIS
5 10 15 20 25
NJUMBER OF CASES
FiG. 3. The sites of extra-medullary lesions in 28 patients examined post mortem.
The stippled column shows the number of cases exhibiting amyloidosis.
Amyloid deposits were observed in 7 cases examined post mortem (21%).
In 4 cases there was widespread involvement corresponding both to primary
and secondary amyloidosis. Two cases showed the patternofprimaryamyloidosis.
and in one case there were deposits in the kidneys. Six patients with amyloi-
dosis were aged between 40 and 50 years, only 2 patients complained of bone
pain, and 5 patients died within one week ofadmission. Severe bleeding manifesta-
tions were the cause of death in 3 of these patients. There was only slight
bone involvement in the patients exhibiting amyloidosis. There was no correla-
tion between amyloidosis and the mobility of the abnormal globulin on
electrophoresis.
There was no increased incidence of other primary malignancies in patients
with multiple myeloma. One patient had previously been treated for carcinoma
of the cervix. One case of multiple myeloma associated with polycythaemia was
observed, and 2 cases exhibited myelofibrosis. Familial incidence was observed
in one instance, a mother and son being affected. In one case multiple myeloma
was diagnosed in the last trimester of pregnancy. The patient had a normal full
term delivery, and has survived 3 years after diagnosis. The child is developing
normally. One possible case of " pre-myeloma " was encountered.
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Solitary plasmocytoma was found to be very uncommon in Jamaica. Two
cases of solitary intra-osseous plasmocytoma were encountered, and both showed
dissemination of the disease after an interval of some years, thus confirming the
close association between solitary plasmocytoma and multiple myeloma. In one
of these cases dissemination occurred 9 years after diagnosis. The only patient
with solitary extra-osseous plasmocytoma was well with no recurrence of the
lesion 2 years after resection of a nasal tumour, and was then lost to follow-up.
The prognosis in these cases was much better than in multiple myeloma, but when
dissemination occurred the prognosis became similar. The rarity of solitary
plasmocytoma in Jamaica can be at least partly explained by the fact that
patients present late in the course of the disease, and by that time dissemination
may already have taken place.
DISCUSSION
Multiple myeloma occurs in all parts of the world, and in all races (Steiner,
1954), but its incidence varies, being relatively high in Western Europe and North
America, and low in Africa, Asia and South America (Doll et al., 1966).
As the Jamaican population is predominantly negro of West African descent,
the comparison ofthe results ofthis study with the reports ofthis disease in parts
of Africa populated by negroes and with those referring to the American negro
may be of special interest. The life expectancy of the Jamaican negro is similar
to that of the African negro, especially above the age of 40 years (Bras, 1967).
In the United States the incidence of multiple myeloma in the negro is similar
to that in the white population (Gilliam, 1953; Carson et al., 1955; Kenny and
Moloney, 1957; Study Committee, 1964; McMahon, 1966). McMahon and Clark
(1956) considered that the incidence was higher in the negro.
The reports from parts of Africa populated by negroes indicate that the inci-
dence of multiple myeloma is low. The disease is very rare in Nigeria (Edington
and Maclean, 1965; McFarlane, 1967, personal communication). Payet et al.
(1963) collected 38 cases from the French speaking West and Central Africa during
a 12 year period. In East Africa the disease is also uncommon. Gelfand (1961)
has not encountered the disease in Rhodesia, and Davies et al. (1965) encountered
only 15 cases in the whole ofUganda in 7 years. Eighteen cases have been recor-
ded in Kenya Africans by Linsell (1967) between 1957-63.
The results ofthe present study, as well as those ofthe Jamaica Cancer Registrv
(Bras et al., 1965) indicate that the incidence of multiple myeloma in Jamaica is
much higher. But it is bv no means as high as has been claimed by McFarlane
(1966), who suggested that the incidence of the disease in Jamaica may be among
the highest in the world.
The age incidence in the present study was similar to that reported in the
recent large series from Europe and North America (Martin, 1961; Study Commit-
tee, 1964; Griffiths, 1966; Nordenson, 1966; Carbone et al., 1967). It has been
stated by McMahon and Clark (1956) as a result of a study of a small number of
cases in Brooklyn, New York, that the disease occurs earlier in the negro than in
white population. But the only other study ofmultiple myeloma in the American
negro (Rosenbaum et al., 1958) from Harlem Hospital, New York, did not support
these observations. The results of the present study also do not support the
findings of McMahon and Clark (1956), in spite of the fact that the majority of
the Jamaican population is young.
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The sex incidence in the present study, which was practically equal, is in
accordance with other recently reported series (Martin, 1961; Griffiths, 1966;
Nordenson, 1966; Carbone et al., 1967), and differs from the earlier findings, which
showed marked male predominance in the ratio of 2-3: 1 (Wallgren, 1921;
Geschicter and Copeland, 1928; Atkinson, 1937).
The clinical findings in the present studv were similar to the findings of other
recent investigators (Snapper et al., 1953; Carson et al., 1955; Kenny and Moloney,
1957; Innes and Newall, 1961; Study Committee, 1964; Griffiths, 1966;
Nordenson, 1966; Carbone et al., 1967), but many patients were admitted in more
advanced stages ofthe disease.
The anaemia on admission was more severe than in the reports mentioned
above, as half the patients had haemoglobin concentration below 9 g./100 ml.
As the absence of anaemia on admission was considered to be one ofthe important
prognostic parameters by Carbone et al. (1967), the severity of anaemia in the
present study correlates well with the poor prognosis.
The biochemical results including serum electrophoresis were similar to those
reported from Europe and North America (Adams et al., 1949; Snapper et al.,
1953; Osserman, 1959; Innes and Newall, 1961; Martin, 1961; Nordenson, 1966).
This is of interest, as Payet et al. (1963) from Dakar have stated that the electro-
phoretic pattern in the African is different, the abnormal band being usually
found in the alpha-2 region. The results of the present study also differ from
those of McFarlane (1966) in Jamaica, who stated that the abnormal band on
electrophoretogram was found to be more common in the beta and alpha-2 regions
than in other reported series. As his study was based on a smaller number of
cases, this is considered to be at least partly due to selection. Immunoglobulin
studies in patients with multiple myeloma in Jamaica (McFarlane et al., unpub-
lished) show similarity to results obtained in the recent studies from Europe and
North America (Martin, 1961; Waldenstrom, 1961; Osserman and Takatsuki,
1963; Alper et al., 1966; Carbone et al., 1967).
The radiological findings did not differ markedly from those reported by other
investigators (Heiser and Schwartzmann, 1952; Snapper et al., 1953; Carson et al.,
1955; Griffiths, 1966). The lesions were similar, but their extent on admission was
often more widespread and the incidence ofpathological fractures was higher.
The prognosis in the present study was poor as compared with recent reports
from Europe and North America (Snapper etal., 1953; Carson etal., 1955; Videbaek
and Johansen, 1956; Study Committee, 1964, and Nordenson, 1966), but was
similar to that reported from Harlem Hospital, New York (Rosenbaum et al.,
1958) and from Dakar, West Africa (Payet et al., 1963). It is not suggested that
the disease has a more rapid course in the negro, but these findings only reflect
the late presentation of patients, the more advanced stage of the disease, and to
some extent lack of the more modern therapeutic facilities. Extra-medullary
involvement at post mortem was common in the present study, supporting the
observations ofrecent investigators (Lowenhaupt, 1945; Churg and Gordon, 1950;
Hayes et al., 1952; Shapiro and Watson, 1953; Snapper et al., 1953, and Carson
et al., 1955), who have emphasised the widespread extra-medullary involvement
produced by the disease, which earlier was considered to be very uncommon
(Geschicter and Copeland, 1928). These findings contradict the results of Payet
et al. (1963) based on a smallnumberofcases, stating that extra-medullary involve-
ment is not observed in the negro. The results of the present study support the
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findings of other investigators (Lichtenstein and Jaffe, 1947; Snapper et al., 1953,
Carson et al., 1955; Innes and Newall, 1961; Griffiths, 1966; Rappaport, 1966)
concerning the better prognosis of solitarv plasmocytoma, and the fact that it is
closely related to multiple myeloma.
SUMMARY
A clinico-pathological study of multiple myeloma in Jamaica was undertaken
in order to examine the disease pattern in a predominantly negro population of
West African origin. During a 10-year period (1957-66) 101 cases of multiple
myeloma and 3 cases of solitary plasmocytoma were encountered. This indicates
that multiple myeloma is more common in Jamaica than in parts of Africa
populated by negroes. The sex incidence was nearly equal, and there was no
evidence that the disease occurs earlier in the negro than in white populations.
The haematological, biochemical, and radiological findings were similar to those
reported from Europe and North America. The majority of patients presented
with advanced disease, and the prognosis was very poor. Post mortem findings
showed a high incidence of extra-medullary involvement and amyloidosis.
This study formed part of a thesis submitted to the University of Sheffield
for the degree of Doctor of Medicine.
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